ProSciento

• NCT04956263

  Collaborator, Phase 2, Completed, 19 people, 9 Jul 2021

• Evaluation of clinical relevance of weight nadirs and weight regain during 3 years of treatment with tirzepatide in participants with obesity or overweight and prediabetes

  Fees or honoraria, Grants or research support, 18 Sept 2026

• Cost-Effectiveness of MASH Diagnosis and Management Approaches Among Those With Type 2 Diabetes

  Fees or honoraria, 3 Nov 2025

• The Cardioprotective Effects of Semaglutide Exceed Those of Dietary Weight Loss in Mice With HFpEF

  Consulting or advice, Board or leadership role, 26 Jul 2023

Sources: europepmc.org, pubmed.ncbi.nlm.nih.gov